Knvul Sheikh handles new research which includes identified a attainable blood marker of unexpected toddler death syndrome (SIDS).Other researchers like David Dowling and Dr. Ofer Levy, the two Ovax co-founders, are utilizing adjuvants that haven’t been tested in individuals but look to efficiently enhance the immune reaction to vaccines targetin